SN
Sonoma Pharmaceuticals, Inc.
SNOA · NASDAQ
$1.31 -2.61% (-$0.04)
1M -2.24%
Market Cap $2.21M
P/E Ratio -
Div. Yield -
ROE 53.56%
Bulios Fair Price
$1.74
33.3% upside
Trenutna cena
$1.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNOA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.33x
P/S 0.10x
EV/EBITDA N/A
Growth
64 /100
Stable Book val. growth 27.06%
Rev. growth 13.74%
FCF growth N/A
Profitability
15 /100
Weak Net margin 10.33%
Op. margin 6.41%
FCF margin 9.82%
Quality
15 /100
Poor ROE 53.56%
ROA 12.50%
Asset turnover 1.21x
Debt
100 /100
Low Current ratio 2.99x
Debt/Equity 0.11x
Net debt/EBITDA N/A
Stability
59 /100
Moderate Rev. volatility 20.50%
EPS volatility 16.36%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNOA
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Amy Trombly
Employees
10
Headquarters
Boulder
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report